Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug delivery
Pharma
FDA approves Corstasis' nasal spray as treatment for edema
The FDA has approved Corstasis Therapeutics’ nasal spray Enbumyst to relieve the edema associated with heart failure and kidney and liver disease.
Kevin Dunleavy
Sep 15, 2025 3:33pm
Manufacturer PCI snares 'sizable' private equity investment
Jul 15, 2025 8:30am
Schott Pharma invests €100M in Hungary manufacturing expansion
Jun 5, 2025 9:40am
Teva forecasts $5B-plus in innovative drug sales by 2030
May 30, 2025 7:20am
Regeneron's Eylea franchise stumbles on several fronts in Q1
Apr 29, 2025 2:50pm
Neurotech nabs first nod for eye disease cell therapy implant
Mar 10, 2025 9:50am
